InvestorsHub Logo
Post# of 252343
Next 10
Followers 8
Posts 219
Boards Moderated 0
Alias Born 02/15/2005

Re: biomaven0 post# 198132

Thursday, 12/10/2015 7:39:07 AM

Thursday, December 10, 2015 7:39:07 AM

Post# of 252343
Take a look @ PTN...

Palatin Technologies Achieves Target Patient Enrollment in Pivotal Phase 3 Studies for Bremelanotide for Female Sexual Dysfunction.

http://finance.yahoo.com/news/palatin-technologies-achieves-target-patient-123000132.html


cl.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.